Search company, investor...

MAKTEAM

makteam.com

Founded Year

2003

Stage

Incubator/Accelerator | Alive

About MAKTEAM

Founded in 2013. MAKTEAM's core product, EvalTools, addresses academic concerns in standard attainment, student evaluations, outcomes assessment as well as gauging teaching effectiveness. EvalTools Higher Ed and EvalToolsK12 are both designed to specifically satisfy higher education and K-12 unique learning environments. The company strives to provide the world-class quality products to enhance academic learning and be your reliable assistant in meeting your educational goals.

Headquarters Location

130 West 8th Street

Erie, Pennsylvania, 16501,

United States

814-528-3435

Missing: MAKTEAM's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: MAKTEAM's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

MAKTEAM Frequently Asked Questions (FAQ)

  • When was MAKTEAM founded?

    MAKTEAM was founded in 2003.

  • Where is MAKTEAM's headquarters?

    MAKTEAM's headquarters is located at 130 West 8th Street, Erie.

  • What is MAKTEAM's latest funding round?

    MAKTEAM's latest funding round is Incubator/Accelerator.

  • Who are the investors of MAKTEAM?

    Investors of MAKTEAM include Erie Technology Incubator.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.